✦ LIBER ✦

Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis

✍ Scribed by G. Zhao; P. Gao; K. H. Yang; J. H. Tian; B. Ma

Book ID: 115184647
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 208 KB
Volume: 12
Category: Article
ISSN: 1462-8910
DOI: 10.1111/j.1463-1318.2009.01879.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus oxaliplatin vs fluorou

Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner – meta-analysis of six randomized trials

✍ Y. Cao; C. Liao; A. Tan; L. Liu; Z. Mo; F. Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Biweekly XELOX (capecitabine and oxalipl

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

669 PUBLICATION Capecitabine and oxalipl

669 PUBLICATION Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced / metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Oxaliplatin, irinotecan and capecitabine

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

✍ Zarate, R; Rodríguez, J; Bandres, E; Patiño-Garcia, A; Ponz-Sarvise, M; Viudez, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 352 KB

Capecitabine and bevacizumab as first-li

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB